An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeutics

Next-generation multi-specific antibody therapeutics (MSATs) are engineered to combine several functional activities into one molecule to provide higher efficacy compared to conventional, mono-specific antibody therapeutics. However, highly engineered MSATs frequently display poor yields and less fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Furtmann, Norbert, Schneider, Marion, Spindler, Nadja, Steinmann, Bjoern, Li, Ziyu, Focken, Ingo, Meyer, Joachim, Dimova, Dilyana, Kroll, Katja, Leuschner, Wulf Dirk, Debeaumont, Audrey, Mathieu, Magali, Lange, Christian, Dittrich, Werner, Kruip, Jochen, Schmidt, Thorsten, Birkenfeld, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366542/
https://www.ncbi.nlm.nih.gov/pubmed/34382900
http://dx.doi.org/10.1080/19420862.2021.1955433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366542/
https://www.ncbi.nlm.nih.gov/pubmed/34382900
http://dx.doi.org/10.1080/19420862.2021.1955433

Ejemplares similares